Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil

This partnership, which marks the entry of Biocon ’s generic formulations into Latin America, builds upon a successful association with Libbs, which began in 2017 to launch biosimilar Trastuzumab in Brazil.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news